Features | Partner Sites | Information | LinkXpress
Sign In
Agfa Healthcare

Quantitative Susceptibility MR Imaging Developed to Monitor Multiple Sclerosis

By Medimaging International staff writers
Posted on 05 Jun 2014
Image: Dr. Ravi Menon, an imaging scientist at Western University’s Robarts Research Institute, used quantitative susceptibility MRI to show and measure damage in specific areas of the brain, which the study showed to be common to all MS and clinically isolated syndrome (CIS) patients (Photo courtesy of Western University).
Image: Dr. Ravi Menon, an imaging scientist at Western University’s Robarts Research Institute, used quantitative susceptibility MRI to show and measure damage in specific areas of the brain, which the study showed to be common to all MS and clinically isolated syndrome (CIS) patients (Photo courtesy of Western University).
Canadian imaging investigators have developed a better way to monitor the progression of multiple sclerosis (MS) at its earliest stages.

Led by Ravi Menon, PhD, from Western University’s Robarts Research Institute (London, Canada), the researchers used a new application called quantitative susceptibility (QS) magnetic resonance imaging (MRI), to gauge impairment in specific areas of the brain that the study showed to be common to all patients. The findings were published online May 28, 2014, in the journal Radiology.

“In MS research, there is something we call a clinical-radiological paradox. When you do conventional MRIs on these patients you see lesions in the brain very clearly, but the number or volume of their lesions do not correlate with the patients’ disabilities. This paradox has been recognized since the MRI was introduced to clinical practice in the early 80s, and yet this is the only imaging tool we have for assessing MS,” said Dr. Menon. “Our research provides a quantitative tool using a relatively conventional imaging sequence but with novel analysis. This tool shows that there is considerable damage occurring in common areas of all patients in both the white matter and in the deep brain structures—the gray matter. Those quantitative measures—what we call quantitative susceptibility—correlate with disease symptoms.”

The process used a conventional Siemens Healthcare (Erlangen, Germany) 3T MRI system so that it could be reproduced in any hospital, using the technique, called QS. The researchers mapped this MRI parameter in 25 patients with relapsing-remitting MS or clinically isolated syndrome (CIS; half of those diagnosed with CIS will go on to be diagnosed with MS) measuring both demyelination and iron deposition. Fifteen age- and sex-matched control study participants were also scanned. Whereas brain and spine lesions visualized with traditional MRI scanning tend to appear and disappear over time, QS revealed common areas of damage in all patients that correlated very well with the extended disability status score (EDSS), which is a standard approach used to measure MS progression, as well as with age and time since diagnosis.

“Significantly, in white matter, even where we see no lesions whatsoever, we’re able to measure damage in the same area of all patients using QS mapping. So even at the very earliest stages of the disease when the disability score is very low, or when the person hasn’t yet been diagnosed with MS, there’s already significant damage,” added Dr. Menon. This could have important diagnostic and prognostic implications, as there are drugs available to slow or stop the progression of MS, if initiated early enough.

Related Links:

Western University’s Robarts Research Institute
Siemens Healthcare



view channel
Image: Bar graph shows the change in detection method over time (1990-2011) for breast cancer cases in patients aged 75 years and older (n = 1162). Pt/PhysD = detection by patient or physician (Photo courtesy of the Radiological Society of North America).

Mammography Screening Helpful for Women Over 75

Mammography-identified breast cancer is associated with a change to earlier-stage diagnosis in older women, which was shown to result in reducing the rate of more advanced, hard-to-treat cases, according... Read more


view channel
Image: Ultrasound image of the Circle of Willis (Photo courtesy of the Swedish Cerebrovascular Center, Seattle, WA, USA).

New Approaches for Transcanial Ultrasound Used for the Treatment of Brain Tumors and Targeted Drug Delivery

A study completed by a Finnish researcher provides new insights into the limitations and potential new directions for the future advancement of transcranial ultrasound therapy. Active research is ongoing... Read more

Nuclear medicine

view channel

PET/CT Using FDG-Labeled Leukocytes Detects Infection in Acute Pancreatitis Patients

A study out of India that identifies infection in patients with pancreatic fluid collections may rapidly and effectively rule out active infection in the body. This treatment may help in making nuclear medicine imaging a mainstay in clinical management practices. Acute pancreatitis (AP) is an abrupt inflammation of the pancreas.... Read more

General/Advanced Imaging

view channel

Diagnostic Imaging Tests Ordered by General Practitioners in Australia Nearly Double in 10 Years

A 45% increase in diagnostic imaging tests ordered by Australian general practitioners (GPs) is being fueled by increasing GP visits, an escalating number of problems managed at doctor visits, and a higher probability that GPs order imaging tests for these problems, according to a new study. Based on a long-term national... Read more

Imaging IT

view channel
Image: An X-ray using the ClearRead bone suppression software technology (Photo courtesy of Riverain Technologies).

Bone Suppression Software Used to Optimize Diagnostic Capability of X-Ray Systems

Clinicians are gathering important information from the most routine imaging exam, the chest X-ray, by using advanced software that enhances X-ray images captured by the equipment they already have or... Read more

Industry News

view channel

Acquisition Includes Radiation Simulation Software for Radiotherapy Applications

Varian Medical Systems, Inc. (Palo Alto, CA, USA) has acquired certain assets of Transpire, Inc. (Gig Harbor, WA, USA) including the Acuros dose calculation software, which has been incorporated into Varian’s BrachyVision and Eclipse treatment planning software systems. The acquisition closed at the end of July 2014.... Read more
Copyright © 2000-2014 Globetech Media. All rights reserved.